Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1997 1
1999 1
2007 1
2008 2
2009 1
2010 1
2011 2
2012 3
2013 2
2016 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice.
Kievit W, Fransen J, Oerlemans AJ, Kuper HH, van der Laar MA, de Rooij DJ, De Gendt CM, Ronday KH, Jansen TL, van Oijen PC, Brus HL, Adang EM, van Riel PL. Kievit W, et al. Among authors: kuper hh. Ann Rheum Dis. 2007 Nov;66(11):1473-8. doi: 10.1136/ard.2007.072447. Epub 2007 Apr 10. Ann Rheum Dis. 2007. PMID: 17426065 Free PMC article. Review.
Initial combination therapy versus step-up therapy in treatment to the target of remission in daily clinical practice in early rheumatoid arthritis patients: results from the DREAM registry.
Steunebrink LM, Versteeg GA, Vonkeman HE, Ten Klooster PM, Kuper HH, Zijlstra TR, van Riel PL, van de Laar MA. Steunebrink LM, et al. Among authors: kuper hh. Arthritis Res Ther. 2016 Mar 8;18:60. doi: 10.1186/s13075-016-0962-9. Arthritis Res Ther. 2016. PMID: 26956382 Free PMC article.
Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort.
Vermeer M, Kuper HH, Moens HJ, Drossaers-Bakker KW, van der Bijl AE, van Riel PL, van de Laar MA. Vermeer M, et al. Among authors: kuper hh. Arthritis Care Res (Hoboken). 2013 Aug;65(8):1219-26. doi: 10.1002/acr.21984. Arthritis Care Res (Hoboken). 2013. PMID: 23436821 Free article. Clinical Trial.
A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry.
Schipper LG, Vermeer M, Kuper HH, Hoekstra MO, Haagsma CJ, Den Broeder AA, van Riel P, Fransen J, van de Laar MA. Schipper LG, et al. Among authors: kuper hh. Ann Rheum Dis. 2012 Jun;71(6):845-50. doi: 10.1136/annrheumdis-2011-200274. Epub 2011 Dec 30. Ann Rheum Dis. 2012. PMID: 22210852
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies.
Kievit W, Fransen J, Adang EM, Kuper HH, Jansen TL, De Gendt CM, De Rooij DJ, Brus HL, van de Laar MA, Van Riel PC. Kievit W, et al. Among authors: kuper hh. Ann Rheum Dis. 2009 Jun;68(6):844-9. doi: 10.1136/ard.2008.094359. Epub 2008 Jul 14. Ann Rheum Dis. 2009. PMID: 18625616
15 results